PMID- 38344612
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240213
IS  - 2168-8184 (Print)
IS  - 2168-8184 (Electronic)
IS  - 2168-8184 (Linking)
VI  - 16
IP  - 1
DP  - 2024 Jan
TI  - Hypoattenuated Leaflet Thickening-Associated Myocardial Infarction: A Rare Case 
      Report and Literature Review.
PG  - e52027
LID - 10.7759/cureus.52027 [doi]
LID - e52027
AB  - Hypoattenuated leaflet thickening (HALT), a potential aftereffect of 
      transcatheter aortic valve replacement (TAVR) procedure, may affect valve 
      performance and clinical outcomes. At this moment we describe an elderly patient 
      who, despite being on prophylactic antiplatelet medication for previous 
      percutaneous intervention (PCI) for coronary artery disease (CAD) and a 
      self-expanding valve in-situ for aortic stenosis (TAVR), presented to the 
      emergency room with non-ST-segment elevation myocardial infarction (NSTEMI), 
      probably as a result of a thromboembolic event from HALT. The case highlights the 
      significance of considering HALT-associated thromboembolism as a potential cause 
      of myocardial infarction (MI) in post-TAVR patients.
CI  - Copyright (c) 2024, Trehan et al.
FAU - Trehan, Shubam
AU  - Trehan S
AD  - Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, IND.
FAU - Singla, Ankur
AU  - Singla A
AD  - Cardiology, Dayanand Medical College and Hospital, Ludhiana, IND.
FAU - Bector, Gaurav
AU  - Bector G
AD  - Medicine and Surgery, Dayanand Medical College and Hospital, Ludhiana, IND.
FAU - Garg, Nadish
AU  - Garg N
AD  - Cardiology, Memorial Hermann Pearland, Pearland, USA.
LA  - eng
PT  - Case Reports
DEP - 20240110
PL  - United States
TA  - Cureus
JT  - Cureus
JID - 101596737
PMC - PMC10854999
OTO - NOTNLM
OT  - cad: coronary artery disease
OT  - dual anti-platelet therapy
OT  - halt
OT  - high-resolution ct
OT  - hypoattenuated leaflet thickening
OT  - st-segment elevation myocardial infarction
OT  - tavr
OT  - transcatheter aortic valve replace
COIS- The authors have declared that no competing interests exist.
EDAT- 2024/02/12 15:42
MHDA- 2024/02/12 15:43
PMCR- 2024/01/10
CRDT- 2024/02/12 04:25
PHST- 2024/01/10 00:00 [accepted]
PHST- 2024/02/12 15:43 [medline]
PHST- 2024/02/12 15:42 [pubmed]
PHST- 2024/02/12 04:25 [entrez]
PHST- 2024/01/10 00:00 [pmc-release]
AID - 10.7759/cureus.52027 [doi]
PST - epublish
SO  - Cureus. 2024 Jan 10;16(1):e52027. doi: 10.7759/cureus.52027. eCollection 2024 
      Jan.